Skip to main content

Table 1 Patient and tumor characteristics

From: Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registry

 

n = 331

Age, years (range)

60 (29–87)

BMI (range)

26.8 (17.3–50.7)

ECOG

 

 0

219 (66%)

 1

108 (33%)

 2

4 (1%)

Laterality

 

 Right

163 (49%)

 Left

168 (51%)

Histology

 

 Invasive ductal

283 (85%)

 Invasive lobular

13 (4%)

 Mixed

5 (2%)

 Other

30 (9%)

Grade

 

 1

71 (21%)

 2

148 (45%)

 3

111 (34%)

 Not reported

1 (< 1%)

pT stage

 

 T0

25 (8%)

 Tis

52 (16%)

 T1

169 (51%)

 T2

63 (19%)

 T3

21 (6%)

 Not reported

1 (< 1%)

Nodal status

 

 Negative

211 (64%)

 Positive

87 (26%)

 Not reported

33 (10%)

ER positive

271 (82%)

PR positive

255 (77%)

HER2 positive

33 (10%)

TNBC

27 (8%)

  1. BMI, body mass index; ECOG, Eastern Cooperative Oncology Group; ER, estrogen receptor; PR, progesterone receptor; TNBC, triple negative breast cancer